Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Keravision(kera) -- Ignore unavailable to you. Want to Upgrade?

To: oilbabe who wrote (282)	12/7/1999 10:21:00 AM
From: Jeff Vayda	Respond to of 338

NEW YORK (CNNfn) - Shares of laser eye surgery equipment maker Visx Inc. tumbled more than 40 percent in early Tuesday trading after a judge made a preliminary ruling against the company in a patent infringement case. Santa Clara, Calif.-based Visx (VISX), which produces refractive laser technology to treat conditions such as nearsightedness and astigmatism, disclosed after Monday?s market close that a judge at the International Trade Commission issued a preliminary ruling in favor of Nidek Co. Ltd. of Japan. Visx said it will seek a review of the ruling. Visx shares dropped 37-5/16 to 50-13/16 at the beginning of Nasdaq trading Tuesday. Shares in the firm had surged from a low of 17-1/8 a year ago to a 52-week high of 103-7/8 in July. According to Visx, it holds more than 140 patents for its laser eye technology worldwide and has about 70 other patents pending. -- from staff and wire reports